Unusual sensitivity to steroid treatment in intractable childhood epilepsy suggests GLUT1 deficiency syndrome

Neuropediatrics

Volumn 43, Issue 5, 2012, Pages 275-278

  Vieker, Silvia ^a   Schmitt, Jörg ^a   Längler, Alfred ^a,b   Schmidt, Winfried ^c   Klepper, Joerg ^d  

^a Gemeinschaftskrankenhaus Herdecke ^*  (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c Labor Lademannsbogen   (Germany)

^d Childrens' Hospital Aschaffenburg   (Germany)

Author keywords

blood brain barrier; childhood epilepsy; dexamethasone; GLUT1; GLUT1 deficiency; ketogenic diet; SLC2A1; steroids

Indexed keywords

DEXAMETHASONE; GLUCOSE TRANSPORTER 1;

ARTICLE; BENIGN CHILDHOOD EPILEPSY; CASE REPORT; CHILD; CORTICOSTEROID THERAPY; CUSHING SYNDROME; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SENSITIVITY; DRUG WITHDRAWAL; FATTY LIVER; FEMALE; GENE MUTATION; GLUCOSE TRANSPORT; GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME; HUMAN; INTRACTABLE EPILEPSY; KETOGENIC DIET; LUMBAR PUNCTURE; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCHOOL CHILD;

ANTICONVULSANTS; CARBOHYDRATE METABOLISM, INBORN ERRORS; CHILD; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MODELS, MOLECULAR; MONOSACCHARIDE TRANSPORT PROTEINS; MUTATION; STEROIDS;

EID: 84867571914     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0032-1324399     Document Type: Article

References (11)

1. Overweg-Plandsoen W. C., Groener J. E., Wang D., et al. GLUT-1 deficiency without epilepsyan exceptional case. J Inherit Metab Dis: 2003; 26 6 559 563 (Pubitemid 37321534)
2. Friedman J. R., Thiele E. A., Wang D., et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord: 2006; 21 2 241 245
3. Zorzi G., Castellotti B., Zibordi F., Gellera C., Nardocci N. Paroxysmal movement disorders in GLUT1 deficiency syndrome. Neurology: 2008; 71 2 146 148
4. Klepper J., Leiendecker B. GLUT1 deficiency syndrome2007 update. Dev Med Child Neurol: 2007; 49 9 707 716
5. Schürmann A., Doege H., Ohnimus H., Monser V., Buchs A., Joost H. G. Role of conserved arginine and glutamate residues on the cytosolic surface of glucose transporters for transporter function. Biochemistry: 1997; 36 42 12897 12902 (Pubitemid 27465401)
6. Williams S. A., Birnbaum M. J. The rat facilitated glucose transporter gene. Transformation and serum-stimulated transcription initiate from identical sites. J Biol Chem: 1988; 263 36 19513 19518 (Pubitemid 19016431)
7. Langdown M. L., Sugden M. C. Enhanced placental GLUT1 and GLUT3 expression in dexamethasone-induced fetal growth retardation. Mol Cell Endocrinol: 2001; 185 1-2 109 117 (Pubitemid 33103959)
8. Olgemöller B., Schön J., Wieland O. H. Endothelial plasma membrane is a glucocorticoid-regulated barrier for the uptake of glucose into the cell. Mol Cell Endocrinol: 1985; 43 2-3 165 171 (Pubitemid 16232510)
9. Guerin C., Wolff J. E., Laterra J., Drewes L. R., Brem H., Goldstein G. W. Vascular differentiation and glucose transporter expression in rat gliomas: effects of steroids. Ann Neurol: 1992; 31 5 481 487
10. Chipkin S. R., van Bueren A., Bercel E., Garrison C. R., McCall A. L. Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature. Neurochem Res: 1998; 23 5 645 652 (Pubitemid 28173569)
11. Ewart H. S., Somwar R., Klip A. Dexamethasone stimulates the expression of GLUT1 and GLUT4 proteins via different signalling pathways in L6 skeletal muscle cells. FEBS Lett: 1998; 421 2 120 124 (Pubitemid 28288075)